Automatic Tube Compensation vs. Pressure Support Ventilation During Spontaneous Breathing Trials in Adults
Launched by RUSH UNIVERSITY MEDICAL CENTER · May 27, 2025
Trial Information
Current as of November 02, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying two different methods to help critically ill adults who are on mechanical ventilation safely breathe on their own again. The goal is to compare "pressure support ventilation" (PSV) and "automatic tube compensation" (ATC) during something called a spontaneous breathing trial (SBT). An SBT is a test that helps doctors decide if it's safe to remove a breathing tube from a patient who has been on a ventilator for more than 24 hours.
To participate in this trial, patients need to be 18 years or older, currently receiving invasive mechanical ventilation in the intensive care unit (ICU), and able to pass a screening for the SBT. However, some individuals may not be eligible, such as those who have a "do not intubate" order, are pregnant, have a tracheostomy, or are enrolled in another clinical trial that might affect the study. If someone does join the trial, they can expect to undergo tests to see which method helps them breathe on their own more effectively, contributing to important research that could improve care for future patients.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Admitted to intensive care unit (ICU)
- • Age 18 years or older
- • Requiring invasive mechanical ventilation for at least 24 hours
- • Pass spontaneous breathing trial screen criteria
- Exclusion Criteria:
- • Clinical decision made not to proceed with extubation regardless of spontaneous breathing trial (SBT) results
- • Do not intubate (DNI) order
- • Presence of tracheostomy
- • Pregnancy
- • Known prisoner
- • Immediate need for extubation, self-extubation, or unplanned extubation that precludes safe performance of study procedures
- • Enrolled in another clinical trial that impacts ventilator weaning or liberation
About Rush University Medical Center
Rush University Medical Center is a leading academic medical institution located in Chicago, Illinois, dedicated to advancing healthcare through innovative research and clinical trials. As a sponsor of numerous clinical studies, Rush focuses on translating scientific discoveries into effective treatments and improving patient outcomes across a variety of medical disciplines. With a commitment to excellence in patient care, education, and research, Rush leverages its state-of-the-art facilities and a robust network of specialists to conduct comprehensive trials that adhere to the highest ethical and regulatory standards. Through collaboration with a diverse patient population, Rush aims to enhance the understanding of diseases and develop novel therapeutic strategies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Chicago, Illinois, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported